Education
About Us
Working with TipRanks
Follow Us
CYBERDYNE Inc. (CYBQF)
OTHER OTC:CYBQF
CYBQF Stock Chart & Stats
$1.08
<$0.01(0.49%)
At close: 4:00 PM EST
$1.08
<$0.01(0.49%)
Day’s Range― - ―
52-Week Range$1.07 - $2.00
Previous CloseN/A
Volume500.00
Average Volume (3M)73.00
Market Cap
$412.23M
Enterprise Value$39.76B
Total Cash (Recent Filing)$15.08B
Total Debt (Recent Filing)$442.00M
Price to Earnings (P/E)19600.0
Beta0.06
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding137,445,820
10 Day Avg. Volume100
30 Day Avg. Volume73
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)0.93
Price to Sales (P/S)8.43
P/FCF Ratio-50.27
Enterprise Value/Market Cap96.46
Enterprise Value/Revenue9.46
Enterprise Value/Gross Profit17.88
Enterprise Value/Ebitda51.91
Forecast
1Y Price Target
$1.70Price Target Upside57.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary HAL PlatformA dedicated, proprietary exoskeleton platform provides a durable competitive moat: specialized tech and clinical use create high switching costs, enable equipment leasing and service revenue, and support long-term adoption by hospitals and rehab centers as a core medical device.
Low Financial LeverageMinimal leverage gives CYBERDYNE structural financial flexibility: the low debt burden reduces solvency risk, enables continued R&D and commercialization spending during downturns, and preserves the capacity to raise targeted capital without immediate distress.
High Gross Profit MarginA >50% gross margin indicates strong unit economics and pricing power at the product level: if sales normalize, these margins can support operating leverage, fund service networks and upgrades, and make long-term profitability achievable with scale.
Bears Say
Sharp Revenue DeclineA near-60% trailing revenue decline is a structural concern: reduced scale weakens network effects, lowers install base for recurring service income, erodes bargaining with distributors, and makes it harder to absorb fixed R&D and support costs over the medium term.
Persistent UnprofitabilityOngoing negative EBIT and net margins constrain retained earnings and reinvestment ability: sustained losses limit capacity to scale commercialization, deter partners, and increase reliance on external funding, raising execution risk for long-term growth plans.
Weak Cash Flow GenerationPersistent negative free cash flow undermines operational resilience: weak cash generation forces reliance on financing, hampers maintenance and service investments critical for medical devices, and increases vulnerability to funding shocks over the next several quarters.
CYBERDYNE News
CYBQF FAQ
What was CYBERDYNE Inc.’s price range in the past 12 months?
CYBERDYNE Inc. lowest stock price was $1.07 and its highest was $2.00 in the past 12 months.
What is CYBERDYNE Inc.’s market cap?
CYBERDYNE Inc.’s market cap is $412.23M.
When is CYBERDYNE Inc.’s upcoming earnings report date?
CYBERDYNE Inc.’s upcoming earnings report date is May 14, 2026 which is in 84 days.
How were CYBERDYNE Inc.’s earnings last quarter?
CYBERDYNE Inc. released its earnings results on Feb 12, 2026. The company reported $0.004 earnings per share for the quarter, beating the consensus estimate of N/A by $0.004.
Is CYBERDYNE Inc. overvalued?
According to Wall Street analysts CYBERDYNE Inc.’s price is currently Undervalued.
Does CYBERDYNE Inc. pay dividends?
CYBERDYNE Inc. does not currently pay dividends.
What is CYBERDYNE Inc.’s EPS estimate?
CYBERDYNE Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYBERDYNE Inc. have?
CYBERDYNE Inc. has 137,445,820 shares outstanding.
What happened to CYBERDYNE Inc.’s price movement after its last earnings report?
CYBERDYNE Inc. reported an EPS of $0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CYBERDYNE Inc.?
Currently, no hedge funds are holding shares in CYBQF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYBERDYNE Inc.
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
CYBQF Stock 12 Month Forecast
Average Price Target
$1.70
▲(57.05% Upside)
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―
Ownership Overview
―
Insiders
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---